Nutrient intake and risk of open-Angle glaucoma: The Rotterdam Study

European Journal of Epidemiology

Volumn 27, Issue 5, 2012, Pages 385-393

  Ramdas, Wishal D ^a   Wolfs, Roger C W ^a   Kiefte De Jong, Jessica C ^a   Hofman, Albert ^a   De Jong, Paulus T V M ^b,c   Vingerling, Johannes R ^a   Jansonius, Nomdo M ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dietary intake; Glaucoma; Magnesium; Nutrition; Population based; Vitamin A; Vitamin B1

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CALCIUM; CAROTENOID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FLAVONOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; MAGNESIUM; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHORUS; PYRIDOXINE; RETINOL; THIAMINE; VITAMIN; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; GENDER; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MINERAL INTAKE; NETHERLANDS; OPEN ANGLE GLAUCOMA; PERIMETRY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; VITAMIN INTAKE;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DIET; DIET SURVEYS; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LINEAR MODELS; MAGNESIUM; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; THIAMINE; VITAMIN A;

EID: 84863720375     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9672-z     Document Type: Article

References (46)

1. Cheung W, Guo L, Cordeiro MF. Neuroprotection in glaucoma: Drug-based approaches. Optom Vis Sci. 2008;85(6):406-16.
2. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006;612(2):105-14.
3. Kumar DM, Agarwal N. Oxidative stress in glaucoma: A burden of evidence. J Glaucoma. 2007;16(3):334-43.
4. Zanon-Moreno V, Marco-Ventura P, Lleo-Perez A, et al. Oxidative stress in primary open-Angle glaucoma. J Glaucoma. 2008; 17(4):263-8.
5. Mozaffarieh M, Grieshaber MC, Orgul S, Flammer J. The potential value of natural antioxidative treatment in glaucoma. Surv Ophthalmol. 2008;53(5):479-505.
6. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005;294(24):3101-7.
7. Rehak M, Fric E, Wiedemann P. Lutein and antioxidants in the prevention of age-related macular degeneration. Ophthalmologe. 2008;105(1):37-38-40-45. doi:10.1007/s00347-007-1602-1.
8. Mozaffarieh M, Flammer J. A novel perspective on natural therapeutic approaches in glaucoma therapy. Expert Opin Emerg Drugs. 2007;12(2):195-8.
9. Cellini M, Caramazza N, Mangiafico P, Possati GL, Caramazza R. Fatty acid use in glaucomatous optic neuropathy treatment. Acta Ophthalmol Scand. 1998;227:41-2.
10. Gaspar AZ, Gasser P, Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica. 1995;209(1):11-3.
11. Kang JH, Pasquale LR, Willett W, et al. Antioxidant intake and primary open-Angle glaucoma: A prospective study. Am J Epidemiol. 2003;158(4):337-46.
12. Kang JH, Pasquale LR, Willett WC, et al. Dietary fat consumption and primary open-Angle glaucoma. Am J Clin Nutr. 2004; 79(5):755-64.
13. West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006;141(1):157-66. doi:10.1016/j.ajo.2005.07.033.
14. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, Kuipers EJ, Nijsten TE, Stricker BH, Tiemeier H, Uitterlinden AG, Vernooij MW, Witteman JC. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011: 26(8):657-86.
15. Dielemans I, Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol. 1994;232(3):141-4.
16. Skenduli-Bala E, de Voogd S, Wolfs RC, et al. Causes of incident visual field loss in a general elderly population: The Rotterdam study. Arch Ophthalmol. 2005;123(2):233-8. doi:10.1001/ archopht.123.2.233.
17. Wolfs RC, Borger PH, Ramrattan RS, et al. Changing views on open-Angle glaucoma: Definitions and prevalences-The Rotterdam Study. Invest Ophthalmol Vis Sci. 2000;41(11):3309-21.
18. Czudowska MA, Ramdas WD, Wolfs RC, et al. Incidence of glaucomatous visual field loss: A ten-year follow-up from the Rotterdam Study. Ophthalmology. 2010;117(9):1705-12.
19. Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur J Clin Nutr. 1998;52(8): 588-96.
20. Goldbohm RA, van den Brandt PA, Brants HA, et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr. 1994;48(4):253-65.
21. Goldbohm RA, van 't Veer P, van den Brandt PA, et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr. 1995;49(6):420-9.
22. Willett W. Nutritional epidemiology. USA: Oxford University Press; 1990.
23. Hollows FC, Graham PA. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol. 1966;50(10):570-86.
24. Lee HP, Casadesus G, Zhu X, et al. All-Trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev Neurother. 2009;9(11):1615-21. doi:10.1586/ern.09.86.
25. McKinnon SJ. Glaucoma: Ocular Alzheimer's disease? Front Biosci. 2003;8:s1140-56.
26. Takasaki J, Ono K, Yoshiike Y, et al. Vitamin A has anti-oligomerization effects on amyloid-beta in vitro. J Alzheimers Dis. 2011;. doi:10.3233/JAD-2011- 110455.
27. Guo L, Salt TE, Luong V, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA. 2007;104(33): 13444-9. doi:10.1073/pnas. 0703707104.
28. Nagashima M, Sakurai H, Mawatari K, Koriyama Y, Matsukawa T, Kato S. Involvement of retinoic acid signaling in goldfish optic nerve regeneration. Neurochem Int. 2009;54(3-4):229-36. doi: 10.1016/j.neuint.2008.11.007.
29. Asregadoo ER. Blood levels of thiamine and ascorbic acid in chronic open-Angle glaucoma. Ann Ophthalmol. 1979;11(7): 1095-100.
30. Head KA. Natural therapies for ocular disorders, part two: Cataracts and glaucoma. Altern Med Rev. 2001;6(2):141-66.
31. Ramakrishna T. Vitamins and brain development. Physiol Res. 1999;48(3):175-87.
32. Suzuki S, Kumanomido T, Nagata E, Inoue J, Niikawa O. Optic neuropathy from thiamine deficiency. Intern Med. 1997;36(7): 532.
33. Ramdas WD, Wolfs RC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. Lifestyle and risk of developing open-Angle glaucoma: The Rotterdam Study. Arch Ophthalmol. 2011;129(6): 767-72. doi:10.1001/archophthalmol.2010.373.
34. Kang KD, Majid AS, Kim KA, et al. Sulbutiamine counteracts trophic factor deprivation induced apoptotic cell death in transformed retinal ganglion cells. Neurochem Res. 2010;35(11): 1828-39. doi:10.1007/s11064-010-0249-5.
35. Mozaffarieh M, Flammer J. Is there more to glaucoma treatment than lowering IOP? Surv Ophthalmol. 2007;52(Suppl 2):S174-9.
36. Winterkorn JM. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Surv Ophthalmol. 1995; 40(1):83-4.
37. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses. 2001;56(2):163-70. doi: 10.1054/mehy.2000.1133.
38. Witteman JC, Grobbee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr. 1994;60(1):129-35.
39. Koseki N, Araie M, Tomidokoro A, et al. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology. 2008;115(11):2049-57. doi:10.1016/j.ophtha. 2008.05.015.
40. Kitazawa Y, Shirai H, Go FJ. The effect of Ca2(+) -Antagonist on visual field in low-Tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 1989;227(5):408-12.
41. Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S. Effects of oral brovincamine on visual field damage in patients with normal-Tension glaucoma with low-normal intraocular pressure. J Glaucoma. 1999;8(2):117-23.
42. Muskens RP, de Voogd S, Wolfs RC, et al. Systemic antihypertensive medication and incident open-Angle glaucoma. Ophthalmology. 2007;114(12):2221-6. doi:10.1016/j.ophtha.2007. 03.047.
43. Langman MJ, Lancashire RJ, Cheng KK, Stewart PM. Systemic hypertension and glaucoma: Mechanisms in common and co-occurrence. Br J Ophthalmol. 2005;89(8):960-3. doi: 10.1136/bjo.2004.053397.
44. Balluz LS, Kieszak SM, Philen RM, Mulinare J. Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey. Arch Fam Med. 2000;9(3):258-62.
45. Messerer M, Johansson SE, Wolk A. Sociodemographic and health behaviour factors among dietary supplement and natural remedy users. Eur J Clin Nutr. 2001;55(12):1104-10. doi: 10.1038/sj.ejcn.1601272.
46. de Voogd S, Ikram MK, Wolfs RC, et al. Is diabetes mellitus a risk factor for open-Angle glaucoma? the Rotterdam Study. Ophthalmology. 2006;113(10):1827-31. doi:10.1016/j.ophtha.2006.03.063.